May 30, 2025

Extra Boost Before Surgery Shows Promise

Tevimbra added to chemo before esophageal cancer surgery doubled complete response rates in a phase 2 trial, hinting at a future shift in standard care.

Reuters

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 20, 2025

Breast Texture Patterns May Detect Missed Cancer

Researchers analyzed over 30,000 mammograms and found that specific breast texture patterns can predict cancer risk and missed diagnoses—even beyond breast density.

Conexiant

May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 06, 2025

Two- vs 8-Week Course of Radiotherapy for Prostate Cancer: 10-Year Follow-up

The phase III HYPO-RT-PC reported 10-year follow-up exploring shorter course radiotherapy for localized prostate cancer. The findings were presented at ESTRO 2025      

The ASCO Post

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

April 01, 2025

FDA Approves Freeze-Dried Jynneos Vaccine

Bavarian Nordic’s freeze-dried Jynneos vaccine offers logistical advantages over the liquid-frozen version, supporting long-term U.S. stockpiling and public health preparedness.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant